FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to medicine and represents medication of endogenous interferon induction, namely to: 6-(3-methoxycarbonylphenyl)amino-2,4 (1H, 3H)pyrimidinedione C12H11N3O4 of general formula .
EFFECT: invention ensures higher activity in injection as well as enteral introduction.
2 tbl, 1 dwg
Title | Year | Author | Number |
---|---|---|---|
METHOD OF TREATING SKIN AND MUCOSAL DISEASES CAUSED BY HERPES SIMPLEX VIRUSES TYPE 1 AND TYPE 2 | 2013 |
|
RU2530587C1 |
FUNGICIDAL AGENT | 2010 |
|
RU2448960C1 |
DRUG PREPARATION WITH ANTIVIRAL ACTIVITY (VERSIONS) | 2015 |
|
RU2595038C1 |
METHOD OF TREATING LIVER DISEASES OF VARIOUS GENESES | 2009 |
|
RU2400233C1 |
DRUG PREPARATION WITH HEPATOPROTECTIVE ACTIVITY | 2015 |
|
RU2595868C1 |
METHOD FOR VIRUS CONTROLLING USING SUBSTANCE BASED ON 2,8-DITHIOXO-1H-PYRANO[2,3-d;6,5-d']DIPYRIMIDINE AND 10-AZA- ANALOGS THEREOF (VARIANTS) | 2005 |
|
RU2294367C2 |
FRACTIONATED ANTIMICROBIAL COMPOSITIONS AND THEIR USE | 2018 |
|
RU2795891C2 |
DRUG FOR TREATMENT OF DISEASES CAUSED BY BACTERIA | 2020 |
|
RU2754610C1 |
METHOD FOR TREATING HUMAN DISEASES ACCOMPANIED WITH INCREASED DNA CONTENT IN EXTRACELLULAR SPACES OF TISSUES AND MEDICINAL PREPARATION FOR ITS REALIZATION | 2005 |
|
RU2308968C2 |
DRUG WITH HERPES VIRUS FAMILY ACTIVITY | 2010 |
|
RU2452490C1 |
Authors
Dates
2011-08-27—Published
2010-11-08—Filed